CLOs on the Move

Guerbet

www.guerbet.com

 
Guerbet is a Bloomington, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.guerbet.com
  • 1185 W 2nd St
    Bloomington, IN USA 47403
  • Phone: 812.333.0059

Executives

Name Title Contact Details
Matt Berkle
Head of U.S. Compliance Profile

Similar Companies

Qvella

Qvella is a molecular diagnostics company with the goal of dramatically reducing time to results in bacteriology. The company has developed a highly differentiated technology for pathogen detection by direct sampling of boldily fluids without the need for culturing or time consuming sample processing.

CosMedical Technologies

For 25 years, we have set the standard for medical grade private label skincare. We have perfected the effectiveness of skincare products and have created an ideal private label experience. Designed for simplicity and efficiency, our branding process is one of the most streamlined and rewarding in the industry. We believe building loyalty to your own brand of quality skincare products is the key to taking your business to the next level and we are here to help you every step of the way.

tei biosciences inc

tei biosciences inc is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

KFx Medical Corporation

KFx Medical Corporation is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HeartFlow

HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow`s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.